News

Published on 21 Nov 2024 on The Motley Fool

3 Dividend Stocks I'll Never Sell | The Motley Fool


Article preview image

As a long-term dividend investor, I've learned that the hardest part of investing isn't finding great companies -- it's having the discipline to hold...

NYSE.MDT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
MDT Stock Gains From FDA Approval for Its InPen App

Medtronic plc MDT recently received Food and Drug Administration (“FDA... smart insulin pen with ...

Zacks · via Yahoo Finance 22 Nov 2024

3 Dividend Stocks I'll Never Sell | The Motley Fool

As a long-term dividend investor, I've learned that the hardest part of investing isn't finding g...

The Motley Fool 21 Nov 2024

Here's Why Medtronic (MDT) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 21 Nov 2024

3 Dividend Stocks I'll Never Sell

As a long-term dividend investor, I've learned that the hardest part of investing isn't finding g...

Motley Fool · via Yahoo Finance 21 Nov 2024

Medtronic plc (MDT): A Key Player in Ken Griffin’s Portfolio with Steady Growth

We recently published a list of Ken Griffin Stock Portfolio: 10 Stocks to Buy. In this article, w...

Insider Monkey · via Yahoo Finance 20 Nov 2024

Jim Cramer on Medtronic plc (MDT): ‘It Has Been A Winner’

We recently compiled a list of the Jim Cramer Is Focused on These 15 Stocks This Week. In this...

Insider Monkey · via Yahoo Finance 20 Nov 2024

Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises...

Tuesday, Medtronic Plc (NYSE:MDT) reported second-quarter 2025 sales of $8.40 billion, beating th...

Benzinga · via AOL 19 Nov 2024

Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View

The Zacks Consensus Estimate for the year’s adjusted earnings is pegged at $5.44 per share. Our T...

Zacks · via Yahoo Finance 19 Nov 2024

Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises...

Tuesday, Medtronic Plc (NYSE:MDT) reported second-quarter 2025 sales of $8.40 billion, beating th...

Benzinga · via Yahoo Finance 19 Nov 2024

International Revenue Growth Makes Medtronic (MDT) An Attractive Investment For...

Medtronic PLC investors have been content with receiving dividends on their holdings for a few ye...

Insider Monkey · via Yahoo Finance 23 Oct 2024